Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma

Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma

Source: News-Medical.Net

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. The team published their findings in the paper, "Selective abrogation of S6K2 identifies l… [3998 chars]

Read more

Leave a Comment

Your email address will not be published.

0